Division of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Ontario, Canada.
Division of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Ontario, Canada.
Int J Surg. 2016 Dec;36(Pt C):513-517. doi: 10.1016/j.ijsu.2016.02.097. Epub 2016 Mar 5.
The incidence of small renal masses (SRMs) has been increasing due to the more liberal use of abdominal imaging. This increased detection has driven the attention of clinicians to the characterization of these lesions and toward a better understanding of their natural history. To this end, renal tumour biopsies (RTBs) have a crucial role as they provide vital pathological information. The improved quality and accuracy of RTBs provide urologists with a very truthful tool to support and guide treatment decisions. The future of RTB will combine pathological, molecular and genetic information that will, improve our knowledge about these lesions and open the potential for risk-adapted personalized medicine.
由于腹部影像学的广泛应用，小肾肿瘤 (SRM) 的发病率不断增加。这种检测的增加引起了临床医生对这些病变的特征及其自然病史的关注。为此，肾肿瘤活检 (RTB) 起着至关重要的作用，因为它提供了重要的病理信息。RTB 的质量和准确性的提高为泌尿科医生提供了一个非常真实的工具，以支持和指导治疗决策。RTB 的未来将结合病理、分子和遗传信息，提高我们对这些病变的认识，并为风险适应的个体化医学开辟潜力。
